Tag: biotechnology
Immutep: Invests nearly $30M for ongoing clinical trials
Biotech company Immutep (IMM) has tapped institutional investors for a neat $29.6 million to fund its cancer and autoimmune diseases treatment trials
The...
Antisense Therapeutics: Raises $7.3M for DMD treatment
Antisense Therapeutics (ANP) has raised $7.3 million for its Duchenne muscular dystrophy (DMD) treatment
The company will issue 73 million shares at 10...
Immutep: Reveals encouraging interim results from phase two TACTI-002 study
Immutep (IMM) has released further interim data from its Phase II TACTI-002 Study in patients with lung, head, and neck cancers
The study...